Persistent parkinsonism and tardive dyskinesia induced by clebopride.
Jiménez-Jiménez
F J
FJ
Department of Neurology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Cabrera-Valdivia
F
F
Ayuso-Peralta
L
L
Tejeiro
J
J
Vaquero
A
A
García-Albea
E
E
D000368:Aged; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
D000932:Antiemetics; D001549:Benzamides; C014417:clebopride